You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Phase III study

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Norovirus Infections, Norwalk Gastroenteritis Trial (Human Norovirus Bivalent (G?.1/G?.4)Vaccine,Recombinant (Hansenula

Not yet recruiting
  • Norovirus Infections
  • Norwalk Gastroenteritis
  • Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine，Recombinant (Hansenula polymorpha)
  • placebo
  • (no location specified)
Jun 14, 2023

Essential Hypertension Trial (AGSAVI, AGLS)

Not yet recruiting
  • Essential Hypertension
  • (no location specified)
Aug 16, 2022

COVID-19 Trial in Kinshasa (EuCorVac-19, ChAdOx1)

Recruiting
  • COVID-19
  • EuCorVac-19
  • ChAdOx1
  • Kinshasa, Congo, The Democratic Republic of the
    Trial site
Nov 1, 2022

Toripalimab, Radiation Trial in Hangzhou (Toripalimab, CRT, SCRT)

Recruiting
  • Toripalimab
  • Radiation
  • Hangzhou, Zhejiang, China
    Zhengjiang Cancer Hospital
Dec 29, 2022

Migraine Trial in New York (RELAXaHEAD Smartphone App Version 1, RELAXaHEAD Smartphone App Version 2)

Not yet recruiting
  • Migraine
  • RELAXaHEAD Smartphone App Version 1
  • RELAXaHEAD Smartphone App Version 2
  • New York, New York
    NYU Langone Health
Oct 5, 2023

Polymyalgia Rheumatica Trial (Secukinumab 300 mg, Secukinumab 150 mg, Placebo to secukinumab)

Not yet recruiting
  • Polymyalgia Rheumatica
  • Secukinumab 300 mg
  • +2 more
  • (no location specified)
Mar 6, 2023

Diagnoses Disease Trial in Montreal, Montréal (DOvEEgene test)

Recruiting
  • Diagnoses Disease
  • DOvEEgene test
  • Montreal, Quebec, Canada
  • +1 more
Aug 23, 2022

HER-2 Positive Breast Cancer Trial in Tianjin (TCbHP VS ddEC-THP)

Recruiting
  • HER-2 Positive Breast Cancer
  • TCbHP VS ddEC-THP
  • Tianjin, Tianjin, China
    Breast Oncology, Tianjin Medical University Cancer Institute and
May 15, 2023

Glabellar Lines Trial (Botulinum Toxin Type A Injection [HG102], Botulinum Toxin Type A Injection [Botox])

Not yet recruiting
  • Glabellar Lines
  • Botulinum Toxin Type A Injection [HG102]
  • Botulinum Toxin Type A Injection [Botox]
  • (no location specified)
Apr 5, 2023

Demodex Infestation Trial in Xiamen, Wuhan (Lotilaner, Vehicle Control)

Recruiting
  • Demodex Infestation
  • Xiamen, Fujian, China
  • +1 more
Nov 17, 2022

Follicular Lymphoma (FL) Trial (biological, drug, other)

Not yet recruiting
  • Follicular Lymphoma (FL)
  • Tisagenlecleucel
  • +4 more
  • (no location specified)
May 24, 2023

Lung Ground-glass Opacities, Watchful Waiting Trial in Shanghai (Watchful waiting)

Not yet recruiting
  • Lung Ground-glass Opacities
  • Watchful Waiting
  • Watchful waiting
  • Shanghai, Shanghai, China
    Fudan University Cancer Center
Oct 19, 2023

Seasonal Influenza Trial in China (Quadrivalent influenza vaccine(0.25ml), Quadrivalent influenza vaccine(0.5ml), Trivalent

Not yet recruiting
  • Seasonal Influenza
  • Quadrivalent influenza vaccine(0.25ml)
  • +3 more
  • Lu'an, Anhui, China
  • +4 more
Sep 15, 2023

Psoriasis Trial in Shanghai (LZM012, Secukinumab)

Recruiting
  • Psoriasis
  • LZM012
  • Secukinumab
  • Shanghai, Shanghai, China
    Huashan Hospital
Oct 29, 2023

Breast Cancer Trial in Beijing (QL1701, Herceptin®, Docetaxel)

Active, not recruiting
  • Breast Cancer
  • Beijing, China
    Cancer Hospital,Chinese Academy of Medical Sciences
Nov 18, 2022

CLL/SLL Trial (lisaftoclax +BTK inhibitor, BTK inhibitor)

Not yet recruiting
  • CLL/SLL
  • lisaftoclax +BTK inhibitor
  • BTK inhibitor
  • (no location specified)
Oct 26, 2023

Varicella Trial in Xuzhou (Investigational live attenuated varicella vaccine, Placebo of live attenuated varicella vaccine)

Recruiting
  • Varicella
  • Investigational live attenuated varicella vaccine
  • Placebo of live attenuated varicella vaccine
  • Xuzhou, Jiangsu, China
    Pei County Center for Disease Control and Prevention
Jan 18, 2023

Covid19 Trial in Tehran (SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant, Saline )

Completed
  • Covid19
  • SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant
  • Saline placebo
  • Tehran, Iran, Islamic Republic of
    Espinas Palace Hotel
Oct 11, 2022

Stress Ulcer Bleeding Trial in Shanghai, Urumchi (Esomeprazole 40mg, Ilaprazole Sodium, Placebo 1)

Completed
  • Stress Ulcer Bleeding
  • Esomeprazole 40mg
  • +3 more
  • Shanghai, Shanghai, China
  • +1 more
Apr 22, 2023

Uterine Fibroids Trial in Germany (Magnetic Resonance Imaging-controlled high-focussed ultrasound therapy, Myomectomy

Recruiting
  • Uterine Fibroids
  • Magnetic Resonance Imaging-controlled high-focussed ultrasound therapy
  • Myomectomy (laparoscopic or open surgical)
  • Frankfurt, Hessen, Germany
  • +3 more
Dec 29, 2022

Cavernous Sinus Meningioma, Proton-therapy, Photon Radiotherapy Trial in France (Proton-therapy, Photon radiotherapy)

Not yet recruiting
  • Cavernous Sinus Meningioma
  • +3 more
  • Proton-therapy
  • Photon radiotherapy
  • Caen, France
  • +6 more
May 31, 2023

Breast Cancer Trial (Dexmedetomidine)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jul 4, 2022

Mucopolysaccharidosis II Trial in Worldwide (JR-141, Idursulfase, JR-141 or Idursulfase)

Recruiting
  • Mucopolysaccharidosis II
  • Oakland, California
  • +8 more
Dec 2, 2022

Allergic Rhinitis Trial (CM310, Placebo)

Not yet recruiting
  • Allergic Rhinitis
  • CM310
  • Placebo
  • (no location specified)
Jun 15, 2023

Functional Dyspepsia Trial in Iksan (DA-5212, DA-5212-R)

Not yet recruiting
  • Functional Dyspepsia
  • Iksan, Muwangro 895, Korea, Republic of
    Wonkwang University Hospital
Apr 24, 2023